Home/Filings/4/0000874716-24-000044
4//SEC Filing

Underberg Sharon E. 4

Accession 0000874716-24-000044

CIK 0000874716other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 5:58 PM ET

Size

29.2 KB

Accession

0000874716-24-000044

Insider Transaction Report

Form 4
Period: 2024-02-14
Underberg Sharon E.
EVP, GC & Corporate Secretary
Transactions
  • Award

    Common Stock

    2024-02-14+2164,980.945 total
  • Award

    Common Stock

    2024-02-14+1385,118.945 total
  • Award

    Common Stock

    2024-02-14+1765,467.945 total
  • Award

    Incentive Stock Option (right-to-buy)

    2024-02-14+178178 total
    Exercise: $560.56Exp: 2034-02-13Common Stock (178 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-14176528 total
    Common Stock (176 underlying)
  • Award

    Common Stock

    2024-02-14+4834,764.945 total
  • Award

    Common Stock

    2024-02-14+1735,291.945 total
  • Award

    Non-Qualified Stock Option (right-to-buy)

    2024-02-14+3,8563,856 total
    Exercise: $560.56Exp: 2034-02-13Common Stock (3,856 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-14138137 total
    Common Stock (138 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-14173346 total
    Common Stock (173 underlying)
  • Tax Payment

    Common Stock

    2024-02-14$560.56/sh356$199,5595,111.945 total
  • Award

    Restricted Stock Unit

    2024-02-14+870870 total
    Common Stock (870 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-144830 total
    Common Stock (483 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2024-02-142160 total
    Common Stock (216 underlying)
Footnotes (9)
  • [F1]Includes a total of 37.247 shares purchased under the Issuer Employee Stock Purchase Plan on June 30, 2023, September 29, 2023 and December 29, 2023.
  • [F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
  • [F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
  • [F4]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
  • [F5]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020.
  • [F6]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021.
  • [F7]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
  • [F8]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
  • [F9]Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001630353

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:58 PM ET
Size
29.2 KB